世界の水疱性類天疱瘡治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Bullous Pemphigoid Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1030
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、97ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、水疱性類天疱瘡治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（免疫抑制薬、ステロイド、抗生物質・防腐剤、鎮痛薬）、用途別市場規模（病院薬局、小売薬局、通信販売薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・水疱性類天疱瘡治療の市場動向
・企業の競争状況、市場シェア
・水疱性類天疱瘡治療の種類別市場規模（免疫抑制薬、ステロイド、抗生物質・防腐剤、鎮痛薬）
・水疱性類天疱瘡治療の用途別市場規模（病院薬局、小売薬局、通信販売薬局）
・水疱性類天疱瘡治療の北米市場規模2016-2027（アメリカ、カナダ）
・水疱性類天疱瘡治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・水疱性類天疱瘡治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・水疱性類天疱瘡治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・水疱性類天疱瘡治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Pfizer、Aqua Pharmaceuticals、Sirius Laboratories、DUBLIN Pharmaceuticals、Teva Pharmaceuticals、Astellas Pharma、Aegis Pharmaceuticals、Sun Pharmaceuticals）
・結論

Bullous pemphigoid is a chronic, inflammatory skin disease that involves the formation of blisters. The bullous may be of different forms such as generalized, vesicular, vegetative, Urticarial, Nodular, Acral or infant forms. The disease is not gender biased and can also occur in younger adults but is rare in infants. The blood blister due to bullous pemphigoid occur in people aging above 70 years. Bullous pemphigoid occurs when the immune system outbreaks a thin layer of tissue below the outer layer of skin. It is more prevalent in patients suffering from dermatitis and neurological disease, predominantly in stroke and dementia. The bullous pemphigoid blister develops on the skin area that tend to flex such as lower abdomen, upper thigh and armpits. Bullous Pemphigoid causes severe itch, tense bullae, annular lesions, post inflammatory pigmentation, blood stained blister fluids and urticaria-like red skin. Proper medication involved in overturning the immune system plays an important role in treatment of the disease.
Rising geriatric population over the globe increase chances of occurrence of disease and thus the surge in treatment options. Common and non-expensive medication uses in the treatment of disease increases fuels the treatment market. Furthermore, various awareness programs by healthcare organizations and NGOs supports the proliferation of treatment market. Non-availability of healthcare facilities in various less developed regions of globe with high incidence rate of disease restricts the overall market to grow.

Market Analysis and Insights: Global Bullous Pemphigoid Treatment Market
The global Bullous Pemphigoid Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Bullous Pemphigoid Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Bullous Pemphigoid Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Bullous Pemphigoid Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Bullous Pemphigoid Treatment market.

Global Bullous Pemphigoid Treatment Scope and Market Size
Bullous Pemphigoid Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bullous Pemphigoid Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Immunosuppressant Medication
Steroids
Antibiotics & Antiseptics
Pain Relief Medication

Segment by Application
Hospitals Pharmacies
Retail Pharmacies
Mail Order Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Aqua Pharmaceuticals
Sirius Laboratories
DUBLIN Pharmaceuticals
Teva Pharmaceuticals
Astellas Pharma
Aegis Pharmaceuticals
Sun Pharmaceuticals

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bullous Pemphigoid Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Immunosuppressant Medication
1.2.3 Steroids
1.2.4 Antibiotics & Antiseptics
1.2.5 Pain Relief Medication
1.3 Market by Application
1.3.1 Global Bullous Pemphigoid Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Mail Order Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Bullous Pemphigoid Treatment Market Perspective (2016-2027)
2.2 Bullous Pemphigoid Treatment Growth Trends by Regions
2.2.1 Bullous Pemphigoid Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Bullous Pemphigoid Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Bullous Pemphigoid Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Bullous Pemphigoid Treatment Industry Dynamic
2.3.1 Bullous Pemphigoid Treatment Market Trends
2.3.2 Bullous Pemphigoid Treatment Market Drivers
2.3.3 Bullous Pemphigoid Treatment Market Challenges
2.3.4 Bullous Pemphigoid Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Bullous Pemphigoid Treatment Players by Revenue
3.1.1 Global Top Bullous Pemphigoid Treatment Players by Revenue (2016-2021)
3.1.2 Global Bullous Pemphigoid Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Bullous Pemphigoid Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Bullous Pemphigoid Treatment Revenue
3.4 Global Bullous Pemphigoid Treatment Market Concentration Ratio
3.4.1 Global Bullous Pemphigoid Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bullous Pemphigoid Treatment Revenue in 2020
3.5 Bullous Pemphigoid Treatment Key Players Head office and Area Served
3.6 Key Players Bullous Pemphigoid Treatment Product Solution and Service
3.7 Date of Enter into Bullous Pemphigoid Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Bullous Pemphigoid Treatment Breakdown Data by Type
4.1 Global Bullous Pemphigoid Treatment Historic Market Size by Type (2016-2021)
4.2 Global Bullous Pemphigoid Treatment Forecasted Market Size by Type (2022-2027)

5 Bullous Pemphigoid Treatment Breakdown Data by Application
5.1 Global Bullous Pemphigoid Treatment Historic Market Size by Application (2016-2021)
5.2 Global Bullous Pemphigoid Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Bullous Pemphigoid Treatment Market Size (2016-2027)
6.2 North America Bullous Pemphigoid Treatment Market Size by Type
6.2.1 North America Bullous Pemphigoid Treatment Market Size by Type (2016-2021)
6.2.2 North America Bullous Pemphigoid Treatment Market Size by Type (2022-2027)
6.2.3 North America Bullous Pemphigoid Treatment Market Size by Type (2016-2027)
6.3 North America Bullous Pemphigoid Treatment Market Size by Application
6.3.1 North America Bullous Pemphigoid Treatment Market Size by Application (2016-2021)
6.3.2 North America Bullous Pemphigoid Treatment Market Size by Application (2022-2027)
6.3.3 North America Bullous Pemphigoid Treatment Market Size by Application (2016-2027)
6.4 North America Bullous Pemphigoid Treatment Market Size by Country
6.4.1 North America Bullous Pemphigoid Treatment Market Size by Country (2016-2021)
6.4.2 North America Bullous Pemphigoid Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Bullous Pemphigoid Treatment Market Size (2016-2027)
7.2 Europe Bullous Pemphigoid Treatment Market Size by Type
7.2.1 Europe Bullous Pemphigoid Treatment Market Size by Type (2016-2021)
7.2.2 Europe Bullous Pemphigoid Treatment Market Size by Type (2022-2027)
7.2.3 Europe Bullous Pemphigoid Treatment Market Size by Type (2016-2027)
7.3 Europe Bullous Pemphigoid Treatment Market Size by Application
7.3.1 Europe Bullous Pemphigoid Treatment Market Size by Application (2016-2021)
7.3.2 Europe Bullous Pemphigoid Treatment Market Size by Application (2022-2027)
7.3.3 Europe Bullous Pemphigoid Treatment Market Size by Application (2016-2027)
7.4 Europe Bullous Pemphigoid Treatment Market Size by Country
7.4.1 Europe Bullous Pemphigoid Treatment Market Size by Country (2016-2021)
7.4.2 Europe Bullous Pemphigoid Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Bullous Pemphigoid Treatment Market Size (2016-2027)
8.2 Asia-Pacific Bullous Pemphigoid Treatment Market Size by Type
8.2.1 Asia-Pacific Bullous Pemphigoid Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Bullous Pemphigoid Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Bullous Pemphigoid Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Bullous Pemphigoid Treatment Market Size by Application
8.3.1 Asia-Pacific Bullous Pemphigoid Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Bullous Pemphigoid Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Bullous Pemphigoid Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Bullous Pemphigoid Treatment Market Size by Region
8.4.1 Asia-Pacific Bullous Pemphigoid Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Bullous Pemphigoid Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Bullous Pemphigoid Treatment Market Size (2016-2027)
9.2 Latin America Bullous Pemphigoid Treatment Market Size by Type
9.2.1 Latin America Bullous Pemphigoid Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Bullous Pemphigoid Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Bullous Pemphigoid Treatment Market Size by Type (2016-2027)
9.3 Latin America Bullous Pemphigoid Treatment Market Size by Application
9.3.1 Latin America Bullous Pemphigoid Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Bullous Pemphigoid Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Bullous Pemphigoid Treatment Market Size by Application (2016-2027)
9.4 Latin America Bullous Pemphigoid Treatment Market Size by Country
9.4.1 Latin America Bullous Pemphigoid Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Bullous Pemphigoid Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Bullous Pemphigoid Treatment Market Size (2016-2027)
10.2 Middle East & Africa Bullous Pemphigoid Treatment Market Size by Type
10.2.1 Middle East & Africa Bullous Pemphigoid Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Bullous Pemphigoid Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Bullous Pemphigoid Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Bullous Pemphigoid Treatment Market Size by Application
10.3.1 Middle East & Africa Bullous Pemphigoid Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Bullous Pemphigoid Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Bullous Pemphigoid Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Bullous Pemphigoid Treatment Market Size by Country
10.4.1 Middle East & Africa Bullous Pemphigoid Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Bullous Pemphigoid Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Bullous Pemphigoid Treatment Introduction
11.1.4 Pfizer Revenue in Bullous Pemphigoid Treatment Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Aqua Pharmaceuticals
11.2.1 Aqua Pharmaceuticals Company Details
11.2.2 Aqua Pharmaceuticals Business Overview
11.2.3 Aqua Pharmaceuticals Bullous Pemphigoid Treatment Introduction
11.2.4 Aqua Pharmaceuticals Revenue in Bullous Pemphigoid Treatment Business (2016-2021)
11.2.5 Aqua Pharmaceuticals Recent Development
11.3 Sirius Laboratories
11.3.1 Sirius Laboratories Company Details
11.3.2 Sirius Laboratories Business Overview
11.3.3 Sirius Laboratories Bullous Pemphigoid Treatment Introduction
11.3.4 Sirius Laboratories Revenue in Bullous Pemphigoid Treatment Business (2016-2021)
11.3.5 Sirius Laboratories Recent Development
11.4 DUBLIN Pharmaceuticals
11.4.1 DUBLIN Pharmaceuticals Company Details
11.4.2 DUBLIN Pharmaceuticals Business Overview
11.4.3 DUBLIN Pharmaceuticals Bullous Pemphigoid Treatment Introduction
11.4.4 DUBLIN Pharmaceuticals Revenue in Bullous Pemphigoid Treatment Business (2016-2021)
11.4.5 DUBLIN Pharmaceuticals Recent Development
11.5 Teva Pharmaceuticals
11.5.1 Teva Pharmaceuticals Company Details
11.5.2 Teva Pharmaceuticals Business Overview
11.5.3 Teva Pharmaceuticals Bullous Pemphigoid Treatment Introduction
11.5.4 Teva Pharmaceuticals Revenue in Bullous Pemphigoid Treatment Business (2016-2021)
11.5.5 Teva Pharmaceuticals Recent Development
11.6 Astellas Pharma
11.6.1 Astellas Pharma Company Details
11.6.2 Astellas Pharma Business Overview
11.6.3 Astellas Pharma Bullous Pemphigoid Treatment Introduction
11.6.4 Astellas Pharma Revenue in Bullous Pemphigoid Treatment Business (2016-2021)
11.6.5 Astellas Pharma Recent Development
11.7 Aegis Pharmaceuticals
11.7.1 Aegis Pharmaceuticals Company Details
11.7.2 Aegis Pharmaceuticals Business Overview
11.7.3 Aegis Pharmaceuticals Bullous Pemphigoid Treatment Introduction
11.7.4 Aegis Pharmaceuticals Revenue in Bullous Pemphigoid Treatment Business (2016-2021)
11.7.5 Aegis Pharmaceuticals Recent Development
11.8 Sun Pharmaceuticals
11.8.1 Sun Pharmaceuticals Company Details
11.8.2 Sun Pharmaceuticals Business Overview
11.8.3 Sun Pharmaceuticals Bullous Pemphigoid Treatment Introduction
11.8.4 Sun Pharmaceuticals Revenue in Bullous Pemphigoid Treatment Business (2016-2021)
11.8.5 Sun Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Bullous Pemphigoid Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Immunosuppressant Medication
Table 3. Key Players of Steroids
Table 4. Key Players of Antibiotics & Antiseptics
Table 5. Key Players of Pain Relief Medication
Table 6. Global Bullous Pemphigoid Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Bullous Pemphigoid Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Bullous Pemphigoid Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Bullous Pemphigoid Treatment Market Share by Regions (2016-2021)
Table 10. Global Bullous Pemphigoid Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Bullous Pemphigoid Treatment Market Share by Regions (2022-2027)
Table 12. Bullous Pemphigoid Treatment Market Trends
Table 13. Bullous Pemphigoid Treatment Market Drivers
Table 14. Bullous Pemphigoid Treatment Market Challenges
Table 15. Bullous Pemphigoid Treatment Market Restraints
Table 16. Global Bullous Pemphigoid Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Bullous Pemphigoid Treatment Market Share by Players (2016-2021)
Table 18. Global Top Bullous Pemphigoid Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bullous Pemphigoid Treatment as of 2020)
Table 19. Ranking of Global Top Bullous Pemphigoid Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Bullous Pemphigoid Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Bullous Pemphigoid Treatment Product Solution and Service
Table 23. Date of Enter into Bullous Pemphigoid Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Bullous Pemphigoid Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Bullous Pemphigoid Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Bullous Pemphigoid Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Bullous Pemphigoid Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Bullous Pemphigoid Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Bullous Pemphigoid Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Bullous Pemphigoid Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Bullous Pemphigoid Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Bullous Pemphigoid Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Bullous Pemphigoid Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Bullous Pemphigoid Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Bullous Pemphigoid Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Bullous Pemphigoid Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Bullous Pemphigoid Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Bullous Pemphigoid Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Bullous Pemphigoid Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Bullous Pemphigoid Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Bullous Pemphigoid Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Bullous Pemphigoid Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Bullous Pemphigoid Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Bullous Pemphigoid Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Bullous Pemphigoid Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Bullous Pemphigoid Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Bullous Pemphigoid Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Bullous Pemphigoid Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Bullous Pemphigoid Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Bullous Pemphigoid Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Bullous Pemphigoid Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Bullous Pemphigoid Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Bullous Pemphigoid Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Bullous Pemphigoid Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Bullous Pemphigoid Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Bullous Pemphigoid Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Bullous Pemphigoid Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Bullous Pemphigoid Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Bullous Pemphigoid Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Bullous Pemphigoid Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Bullous Pemphigoid Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Pfizer Company Details
Table 64. Pfizer Business Overview
Table 65. Pfizer Bullous Pemphigoid Treatment Product
Table 66. Pfizer Revenue in Bullous Pemphigoid Treatment Business (2016-2021) & (US$ Million)
Table 67. Pfizer Recent Development
Table 68. Aqua Pharmaceuticals Company Details
Table 69. Aqua Pharmaceuticals Business Overview
Table 70. Aqua Pharmaceuticals Bullous Pemphigoid Treatment Product
Table 71. Aqua Pharmaceuticals Revenue in Bullous Pemphigoid Treatment Business (2016-2021) & (US$ Million)
Table 72. Aqua Pharmaceuticals Recent Development
Table 73. Sirius Laboratories Company Details
Table 74. Sirius Laboratories Business Overview
Table 75. Sirius Laboratories Bullous Pemphigoid Treatment Product
Table 76. Sirius Laboratories Revenue in Bullous Pemphigoid Treatment Business (2016-2021) & (US$ Million)
Table 77. Sirius Laboratories Recent Development
Table 78. DUBLIN Pharmaceuticals Company Details
Table 79. DUBLIN Pharmaceuticals Business Overview
Table 80. DUBLIN Pharmaceuticals Bullous Pemphigoid Treatment Product
Table 81. DUBLIN Pharmaceuticals Revenue in Bullous Pemphigoid Treatment Business (2016-2021) & (US$ Million)
Table 82. DUBLIN Pharmaceuticals Recent Development
Table 83. Teva Pharmaceuticals Company Details
Table 84. Teva Pharmaceuticals Business Overview
Table 85. Teva Pharmaceuticals Bullous Pemphigoid Treatment Product
Table 86. Teva Pharmaceuticals Revenue in Bullous Pemphigoid Treatment Business (2016-2021) & (US$ Million)
Table 87. Teva Pharmaceuticals Recent Development
Table 88. Astellas Pharma Company Details
Table 89. Astellas Pharma Business Overview
Table 90. Astellas Pharma Bullous Pemphigoid Treatment Product
Table 91. Astellas Pharma Revenue in Bullous Pemphigoid Treatment Business (2016-2021) & (US$ Million)
Table 92. Astellas Pharma Recent Development
Table 93. Aegis Pharmaceuticals Company Details
Table 94. Aegis Pharmaceuticals Business Overview
Table 95. Aegis Pharmaceuticals Bullous Pemphigoid Treatment Product
Table 96. Aegis Pharmaceuticals Revenue in Bullous Pemphigoid Treatment Business (2016-2021) & (US$ Million)
Table 97. Aegis Pharmaceuticals Recent Development
Table 98. Sun Pharmaceuticals Company Details
Table 99. Sun Pharmaceuticals Business Overview
Table 100. Sun Pharmaceuticals Revenue in Bullous Pemphigoid Treatment Business (2016-2021) & (US$ Million)
Table 101. Sun Pharmaceuticals Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bullous Pemphigoid Treatment Market Share by Type: 2020 VS 2027
Figure 2. Immunosuppressant Medication Features
Figure 3. Steroids Features
Figure 4. Antibiotics & Antiseptics Features
Figure 5. Pain Relief Medication Features
Figure 6. Global Bullous Pemphigoid Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Mail Order Pharmacies Case Studies
Figure 10. Bullous Pemphigoid Treatment Report Years Considered
Figure 11. Global Bullous Pemphigoid Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Bullous Pemphigoid Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Bullous Pemphigoid Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Bullous Pemphigoid Treatment Market Share by Regions (2022-2027)
Figure 15. Global Bullous Pemphigoid Treatment Market Share by Players in 2020
Figure 16. Global Top Bullous Pemphigoid Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bullous Pemphigoid Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Bullous Pemphigoid Treatment Revenue in 2020
Figure 18. Global Bullous Pemphigoid Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Bullous Pemphigoid Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Bullous Pemphigoid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Bullous Pemphigoid Treatment Market Share by Type (2016-2027)
Figure 22. North America Bullous Pemphigoid Treatment Market Share by Application (2016-2027)
Figure 23. North America Bullous Pemphigoid Treatment Market Share by Country (2016-2027)
Figure 24. United States Bullous Pemphigoid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Bullous Pemphigoid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Bullous Pemphigoid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Bullous Pemphigoid Treatment Market Share by Type (2016-2027)
Figure 28. Europe Bullous Pemphigoid Treatment Market Share by Application (2016-2027)
Figure 29. Europe Bullous Pemphigoid Treatment Market Share by Country (2016-2027)
Figure 30. Germany Bullous Pemphigoid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Bullous Pemphigoid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Bullous Pemphigoid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Bullous Pemphigoid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Bullous Pemphigoid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Bullous Pemphigoid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Bullous Pemphigoid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Bullous Pemphigoid Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Bullous Pemphigoid Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Bullous Pemphigoid Treatment Market Share by Region (2016-2027)
Figure 40. China Bullous Pemphigoid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Bullous Pemphigoid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Bullous Pemphigoid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Bullous Pemphigoid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Bullous Pemphigoid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Bullous Pemphigoid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Bullous Pemphigoid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Bullous Pemphigoid Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Bullous Pemphigoid Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Bullous Pemphigoid Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Bullous Pemphigoid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Bullous Pemphigoid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Bullous Pemphigoid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Bullous Pemphigoid Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Bullous Pemphigoid Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Bullous Pemphigoid Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Bullous Pemphigoid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Bullous Pemphigoid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Bullous Pemphigoid Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Pfizer Revenue Growth Rate in Bullous Pemphigoid Treatment Business (2016-2021)
Figure 60. Aqua Pharmaceuticals Revenue Growth Rate in Bullous Pemphigoid Treatment Business (2016-2021)
Figure 61. Sirius Laboratories Revenue Growth Rate in Bullous Pemphigoid Treatment Business (2016-2021)
Figure 62. DUBLIN Pharmaceuticals Revenue Growth Rate in Bullous Pemphigoid Treatment Business (2016-2021)
Figure 63. Teva Pharmaceuticals Revenue Growth Rate in Bullous Pemphigoid Treatment Business (2016-2021)
Figure 64. Astellas Pharma Revenue Growth Rate in Bullous Pemphigoid Treatment Business (2016-2021)
Figure 65. Aegis Pharmaceuticals Revenue Growth Rate in Bullous Pemphigoid Treatment Business (2016-2021)
Figure 66. Sun Pharmaceuticals Revenue Growth Rate in Bullous Pemphigoid Treatment Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

以下、関連資料のご紹介

世界の脂質障害治療市場規模・現状・予測（2021年-2027年）

Global Lipid Disorder Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3432 2021年4月 98Pages
QYResearch社発行の本調査資料では、脂質障害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アトルバスタチン、フルバスタチン、ロスバスタチン、シンバスタチン、プラバスタチン、その他）、用途別市場規模（病院、クリニック、その他）、主要...

世界のジフテリア治療市場規模・現状・予測（2021年-2027年）

Global Diphtheria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1902 2021年4月 95Pages
QYResearch社発行の本調査資料では、ジフテリア治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（破傷風免疫グロブリン、破傷風トキソイド、破傷風-ジフテリア、ジフテリアトキソイド、百日咳）、用途別市場規模（抗毒素、抗生物質、その他）、主...

世界のナルコレプシー治療市場規模・現状・予測（2021年-2027年）

Global Narcolepsy Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4022 2021年4月 94Pages
QYResearch社発行の本調査資料では、ナルコレプシー治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（オキシベートナトリウム、抗うつ薬、中枢神経刺激薬、その他）、用途別市場規模（脱力発作を伴う原発性ナルコレプシー、脱力発作を伴わない原発...

世界の多発性内分泌腺腫症治療市場規模・現状・予測（2021年-2027年）

Global Multiple Endocrine Neoplasia Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3952 2021年4月 97Pages
QYResearch社発行の本調査資料では、多発性内分泌腺腫症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、外科治療）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中...

世界の軟骨肉腫治療市場規模・現状・予測（2021年-2027年）

Global Chondrosarcoma Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1305 2021年4月 99Pages
QYResearch社発行の本調査資料では、軟骨肉腫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（外科的治療、化学療法、放射線療法）、用途別市場規模（病院、専門クリニック、がん治療センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ...

世界の裂肛治療市場規模・現状・予測（2021年-2027年）

Global Anal Fissure Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0309 2021年4月 91Pages
QYResearch社発行の本調査資料では、裂肛治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（局所ニトログリセリン、カルシウムチャネル遮断薬、便軟化剤、その他）、用途別市場規模（クリニック、病院、その他）、主要地域別市場規模（北米、アメリ...

世界の早産治療市場規模・現状・予測（2021年-2027年）

Global Premature Labor Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4769 2021年4月 93Pages
QYResearch社発行の本調査資料では、早産治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（プロゲステロン、OBE-022、レトシバン、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、ア...

世界の消化器疾患治療市場規模・現状・予測（2021年-2027年）

Global Digestive Distress Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1859 2021年4月 92Pages
QYResearch社発行の本調査資料では、消化器疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（上部消化管、下部消化管）、用途別市場規模（病院薬局、オンライン薬局、ドラッグストア、専門クリニック）、主要地域別市場規模（北米、アメリカ、...

世界のハンセン病治療市場規模・現状・予測（2021年-2027年）

Global Leprosy Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3400 2021年4月 91Pages
QYResearch社発行の本調査資料では、ハンセン病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（スルホン、フェナジン誘導体、抗管状薬、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ...

世界の痙性治療市場規模・現状・予測（2021年-2027年）

Global Spasticity Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5383 2021年4月 99Pages
QYResearch社発行の本調査資料では、痙性治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（理学療法、医学治療）、用途別市場規模（子供用、大人用）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南ア...

世界の市販鎮痛薬市場規模・現状・予測（2021年-2027年） Over-the-counter pain medication are very helpful for the person suffering from minor and major pain. As the over-the-counter are easily available without proper prescriptions and very effective to control the pain. Over-the-counter pain medication are approved product from the regulatory authority,…
世界の市販鎮痛薬市場規模・現状・予測（2021年-2027年） Over-the-counter pain medication are very helpful for the person suffering from minor and major pain. As the over-the-counter are easily available without proper prescriptions and very effective to control the pain. Over-the-counter pain medication are approved product from the regulatory authority,…
世界の自己管理薬市場規模・現状・予測（2021年-2027年） Self-administration is, in its medical sense, the process of a subject administering a pharmacological substance to themself. A clinical example of this is the subcutaneous "self-injection" of insulin by a diabetic patient. By distribution channel, the hospital pharmacies segment is expected to repr…
世界の逆流性腎症治療市場規模・現状・予測（2021年-2027年） Reflux nephropathy is kidney damage (nephropathy) due to urine flowing backward (reflux) from the bladder toward the kidneys. The symptoms of reflux nephropathy are comparable to nephrotic syndrome and infection of the urinary tract, though some individuals may not exhibit any evidence (symptom) of …
世界の服薬アドヒアランス包装システム市場規模・現状・予測（2021年-2027年） Medication Adherence Packaging Systems can increase pharmacy efficiency in order to improve patients' adherence to their medication. The classification of Medication Adherence Packaging includes Unit-dose Adherence Blister Cards, Unit-dose Adherence Pouches, Multi-dose Adherence Blister Cards, Multi…